M11.252
Other chondrocalcinosis, left hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Chondrocalcinosis, also known as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, involves the buildup of calcium crystals in the cartilage of joints. When these deposits occur specifically in the left hip, the condition is classified under the ICD-10 code M11.252. While often associated with aging, chondrocalcinosis can lead to joint pain and mobility issues, impacting quality of life. Recognizing the signs and understanding the underlying causes are crucial steps toward managing this condition effectively.
Causes & Symptoms
Clinical Causes: Aging, which naturally leads to cartilage changes and crystal deposition Genetic predisposition, making some individuals more prone to crystal formation Joint trauma or injury that disrupts normal cartilage function Metabolic disorders such as hyperparathyroidism, hemochromatosis, or hypophosphatasia Other joint diseases or degenerative conditions that influence cartilage health
Key Symptoms: Joint pain, often worsening with activity or after periods of inactivity Swelling around the affected joint, sometimes accompanied by warmth Limited range of motion in the hip, leading to stiffness Tenderness to touch around the hip area Possible episodic flare-ups with increased discomfort and swelling
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and imaging studies. Imaging techniques like X-rays can reveal characteristic deposits of calcium within the cartilage of the hip joint, confirming chondrocalcinosis. In some cases, joint fluid analysis may be performed to identify CPPD crystals directly under a microscope. Blood tests might also be utilized to detect underlying metabolic conditions that contribute to crystal formation. Accurate diagnosis is essential for differentiating chondrocalcinosis from other arthritic conditions, such as osteoarthritis or gout.
Treatment Protocols: Management of chondrocalcinosis focuses on alleviating symptoms and slowing joint deterioration. Common approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation - Corticosteroid injections into the affected joint for severe flare-ups - Physical therapy exercises to improve strength, flexibility, and joint function - Lifestyle modifications such as weight management and activity adjustments - Addressing underlying metabolic conditions that may contribute to crystal formation In some cases, surgical options like joint replacement might be considered if joint damage is advanced. Regular monitoring and consultation with healthcare professionals are key to managing this condition effectively.
Clinical Advice & FAQs
Billing Guidance
Is M11.252 a billable ICD-10 code?
Yes, M11.252 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.252?
Clinical documentation must specify the nature of Other chondrocalcinosis, left hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference